CORONA in the Saarland
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Cytokine measurements.
- Who it may be relevant to
- Registry conditions: Covid19. Basic parameters: 0 years — 110 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Germany
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The CORSAAR study is an observational, prospective study to investigate the natural biology of COVID-19
Detailed description
Patients with all forms of COVID-19 are included and followed up. Medical history, measurements and biomarkers are registered and collected at baseline, dung hospitalization and after discharge. In addition, patients with LONG-COVID-19 are recruited.
Interventions
- Diagnostic test Cytokine measurements
The serum concentrations of multiple cytokines are measured.
Primary outcome measures
- Correlation of biomarkers with mortality and disease subgroups [Time frame: 2 years after initial disease]
Eligibility criteria
Inclusion criteria
all form of COVID-19 including long-COVID-19
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
Germany · 1 center
- Saarland University — Homburg
Identifiers
NCT: NCT04837755 · CORSAAR1